IL- 21 and Immune Mediated Viral Control
IL- 21 and Immune Mediated Viral Control
批准号:
8460850
负责人:
Allan J Zajac
金额:
$43.78万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-01 至 2015-04-30
关键词:
AcuteAntibody FormationB-LymphocytesCD4 Positive T LymphocytesCD8B1 geneCellsChronicDefectDependencyDevelopmentGenerationsHelper-Inducer T-LymphocyteHeterogeneityHumanImmuneImmunityImmunologic MemoryInfectionInfection ControlLifeLongevityMediatingPlayRoleShapesSignal TransductionSourceT cell responseT memory cellT-LymphocyteT-Lymphocyte SubsetsTherapeuticTherapeutic EffectViralVirus Diseasesbasecombatexhaustionfunctional disabilityresponse
中文摘要
描述(由申请人提供):深入了解调节抗病毒T细胞反应的诱导、质量和寿命的因素对于设计合理的策略来对抗病毒感染至关重要。强大的抗病毒免疫的一个标志是有效的CD4和CD8 T细胞反应的阐述,它们协同作用以控制感染。无效反应的后果可能是灾难性的,导致病毒持续存在或长期免疫记忆的丧失。然而,驱动最强大的多功能效应反应的发展和指示记忆T细胞出现的信号尚未完全了解。本提案的目的是利用令人信服的初步发现,表明IL-21在抗病毒免疫中起着至关重要的作用。我们的初步研究清楚地表明,如果没有足够水平的IL-21,多功能效应CD8 T细胞的产生就会受到损害,并且在慢性感染期间,T细胞衰竭会明显加剧。值得注意的是,在缺乏IL-21的情况下,抗病毒CDS T细胞的许多表型和功能损伤类似于在CD4 T细胞缺陷宿主中观察到的缺陷。IL-21的主要生产者是CD4滤泡辅助细胞(Tfh),其功能是帮助抗体反应,因此Tfh衍生的IL-21可能是帮助CD8 T细胞反应的关键因素。然而,目前尚不清楚IL-21是否直接或间接作用于抗病毒CD8 T细胞以促进其功能,IL-21如何塑造T细胞异质性,Tfh是否是IL-21的基本细胞来源,以及基于IL-21的治疗是否在急性和慢性感染期间对病毒控制具有治疗益处。因此,我们提出以下具体目标:1)。确定IL-21对多功能抗病毒CDS T细胞的直接作用。2). 阐明CD4 T细胞来源的IL-21在促进抗病毒免疫中的作用。3). 确定在人类病毒感染过程中产生il -21的CD4 T细胞的意义4)。确定IL-21对抗病毒免疫和控制的治疗效果。
英文摘要
DESCRIPTION (provided by applicant): Developing an in-depth understanding of the factors that regulate the induction, quality, and longevity of anti- viral T cell responses is essential for devising rational strategies to combat viral infections. A hallmark of robust anti-viral immunity is the elaboration of potent CD4 and CD8 T cell responses which act cooperatively to bring about control of the infection. The consequences of ineffective responses can be catastrophic, resulting in viral persistence or the loss of long-lived immunological memory. Nevertheless, the signals which drive the development of the most robust polyfunctional effector responses and dictate the emergence of memory T cells are not fully understood. The purpose of this proposal is to capitalize on compelling preliminary findings which indicate that IL-21 plays a vital role in anti-viral immunity. Our initial studies clearly show that without sufficient levels of IL-21 the generation of polyfunctional effector CD8 T cells is compromised, and quite strikingly T cell exhaustion is exacerbated during chronic infections. Significantly, many of the phenotypic and functional impairments in anti-viral CDS T cells which manifest in the absence of IL-21 resemble the defects observed in CD4 T cell deficient hosts. A principal producer of IL-21 are CD4 follicular helper cells (Tfh) which function to help antibody responses, therefore Tfh derived IL-21 may be the critical factor that helps CD8 T cell responses. It is, however, unclear whether IL-21 is acting directly or indirectly on anti-viral CD8 T cells to promote their functionality, how T cell heterogeneity is shaped by IL-21, whether Tfh are the essential cellular sources of IL-21, and whether IL-21 based treatments have therapeutic benefits on viral control both during acute and chronic infection. We therefore propose the following specific aims: 1). Determine the direct effects of IL-21 on polyfunctional anti-viral CDS T cells. 2). Elucidate the role of CD4 T cell-derived IL-21 in promoting anti-viral immunity. 3). Define the significance of IL-21-producing CD4 T cells during viral infections of humans 4). Determine the therapeutic effects of IL-21 on anti-viral immunity and control.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.2337/db11-0880
发表时间:
2011-12
期刊:
Diabetes
影响因子:
7.7
作者:
[Petrelli A, Carvello M, Vergani A, Lee KM, Tezza S, Du M, Kleffel S, Chengwen L, Mfarrej BG, Hwu P, Secchi A, Leonard WJ, Young D, Sayegh MH, Markmann JF, Zajac AJ, Fiorina P]
通讯作者:
Fiorina P
Resistance to T cell exhaustion
-
批准号:10362235
-
项目类别:
-
资助金额:$53.7万
-
财政年份:2021
-
负责人:Allan J Zajac
-
依托单位:
Resistance to T cell exhaustion
-
批准号:10684084
-
项目类别:
-
资助金额:$53.7万
-
财政年份:2021
-
负责人:Allan J Zajac
-
依托单位:
The Regulation of T Cell Exhaustion by Adhesion Molecules
-
批准号:8290753
-
项目类别:
-
资助金额:$18.31万
-
财政年份:2012
-
负责人:Allan J Zajac
-
依托单位:
The Regulation of T Cell Exhaustion by Adhesion Molecules
-
批准号:8416362
-
项目类别:
-
资助金额:$21.98万
-
财政年份:2012
-
负责人:Allan J Zajac
-
依托单位:
Flow Cytometry
-
批准号:7685024
-
项目类别:
-
资助金额:$23.6万
-
财政年份:2009
-
负责人:Allan J Zajac
-
依托单位:
IL- 21 and Immune Mediated Viral Control
-
批准号:7802289
-
项目类别:
-
资助金额:$47.06万
-
财政年份:2009
-
负责人:Allan J Zajac
-
依托单位:
IL- 21 and Immune Mediated Viral Control
-
批准号:7679777
-
项目类别:
-
资助金额:$46.09万
-
财政年份:2009
-
负责人:Allan J Zajac
-
依托单位:
IL- 21 and Immune Mediated Viral Control
-
批准号:8261140
-
项目类别:
-
资助金额:$46.57万
-
财政年份:2009
-
负责人:Allan J Zajac
-
依托单位:
IL- 21 and Immune Mediated Viral Control
-
批准号:8067761
-
项目类别:
-
资助金额:$46.59万
-
财政年份:2009
-
负责人:Allan J Zajac
-
依托单位:
Flow Cytometry
-
批准号:7697011
-
项目类别:
-
资助金额:$7.14万
-
财政年份:2008
-
负责人:Allan J Zajac
-
依托单位:
Helper-Dependent CD8 T Cell Memory
-
批准号:7146832
-
项目类别:
-
资助金额:$29.1万
-
财政年份:2006
-
负责人:Allan J Zajac
-
依托单位:
Helper-Dependent CD8 T Cell Memory
-
批准号:7485697
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2006
-
负责人:Allan J Zajac
-
依托单位:
Helper-Dependent CD8 T Cell Memory
-
批准号:7675254
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2006
-
负责人:Allan J Zajac
-
依托单位:
Helper-Dependent CD8 T Cell Memory
-
批准号:7286263
-
项目类别:
-
资助金额:$28.26万
-
财政年份:2006
-
负责人:Allan J Zajac
-
依托单位:
Regulation of T Cell Activity During Chronic Infections
-
批准号:6632324
-
项目类别:
-
资助金额:$21.53万
-
财政年份:2001
-
负责人:Allan J Zajac
-
依托单位:
Regulation of T Cell Activity During Chronic Infections
-
批准号:8004072
-
项目类别:
-
资助金额:$27.88万
-
财政年份:2001
-
负责人:Allan J Zajac
-
依托单位:
Regulation of T Cell Activity During Chronic Infections
-
批准号:6511345
-
项目类别:
-
资助金额:$21.53万
-
财政年份:2001
-
负责人:Allan J Zajac
-
依托单位:
Regulation of T Cell Activity During Chronic Infections
-
批准号:8883784
-
项目类别:
-
资助金额:$36.23万
-
财政年份:2001
-
负责人:Allan J Zajac
-
依托单位:
Regulation of T Cell Activity During Chronic Infections
-
批准号:7557884
-
项目类别:
-
资助金额:$28.45万
-
财政年份:2001
-
负责人:Allan J Zajac
-
依托单位:
Regulation of T Cell Activity During Chronic Infections
-
批准号:6876101
-
项目类别:
-
资助金额:$21.53万
-
财政年份:2001
-
负责人:Allan J Zajac
-
依托单位:
海外基金